A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). https://t.co/hdMw7O9cOa
162 followers
526 followers
A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF) #endpointadjudication https://t.co/vPJjG4TVS
339 followers
RT @cosjor: John JV Murray https://t.co/58JToR1wgT En sesión estatutaria de SMC 13 y 14 de marzo. Hotel Marquís Reforma . @cosjor @VpSMC2…
2,278 followers
RT @cosjor: John JV Murray https://t.co/58JToR1wgT En sesión estatutaria de SMC 13 y 14 de marzo. Hotel Marquís Reforma . @cosjor @VpSMC2…